These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 8315077)

  • 1. Use of a durometer to assess skin hardness.
    Falanga V; Bucalo B
    J Am Acad Dermatol; 1993 Jul; 29(1):47-51. PubMed ID: 8315077
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Use of a durometer to measure the degree of skin induration in lipodermatosclerosis.
    Romanelli M; Falanga V
    J Am Acad Dermatol; 1995 Feb; 32(2 Pt 1):188-91. PubMed ID: 7829701
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Durometer measurements of skin induration in venous disease.
    LeBlanc N; Falabella A; Murata H; Hasan A; Weiss E; Falanga V
    Dermatol Surg; 1997 Apr; 23(4):285-7. PubMed ID: 9149796
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Validity, reliability, and feasibility of durometer measurements of scleroderma skin disease in a multicenter treatment trial.
    Merkel PA; Silliman NP; Denton CP; Furst DE; Khanna D; Emery P; Hsu VM; Streisand JB; Polisson RP; Akesson A; Coppock J; van den Hoogen F; Herrick A; Mayes MD; Veale D; Seibold JR; Black CM; Korn JH; ;
    Arthritis Rheum; 2008 May; 59(5):699-705. PubMed ID: 18438905
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Durometry for the assessment of skin disease in systemic sclerosis.
    Kissin EY; Schiller AM; Gelbard RB; Anderson JJ; Falanga V; Simms RW; Korn JH; Merkel PA
    Arthritis Rheum; 2006 Aug; 55(4):603-9. PubMed ID: 16874783
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The correlation between durometer score and modified Rodnan skin score in systemic sclerosis.
    Moon KW; Song R; Kim JH; Lee EY; Lee EB; Song YW
    Rheumatol Int; 2012 Aug; 32(8):2465-70. PubMed ID: 21769489
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A stretchable hardness sensor for the assessment of skin disease in systemic sclerosis.
    Wang X; Liu M; Ye T; Huang J; Xu X; Li M; Zhao X; Lu H; Yang J
    RMD Open; 2023 Nov; 9(4):. PubMed ID: 37996124
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Quantification of hardness, elasticity and viscosity of the skin of patients with systemic sclerosis using a novel sensing device (Vesmeter): a proposal for a new outcome measurement procedure.
    Kuwahara Y; Shima Y; Shirayama D; Kawai M; Hagihara K; Hirano T; Arimitsu J; Ogata A; Tanaka T; Kawase I
    Rheumatology (Oxford); 2008 Jul; 47(7):1018-24. PubMed ID: 18440998
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reproducible measurements to quantify cutaneous involvement in scleroderma.
    Aghassi D; Monoson T; Braverman I
    Arch Dermatol; 1995 Oct; 131(10):1160-6. PubMed ID: 7574833
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Period of remission after treatment with UVA-1 in sclerodermic skin diseases.
    Kroft EB; van de Kerkhof PC; Gerritsen MJ; de Jong EM
    J Eur Acad Dermatol Venereol; 2008 Jul; 22(7):839-44. PubMed ID: 18452527
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vivo study of skin mechanical properties in Raynaud's phenomenon.
    Dobrev H
    Skin Res Technol; 2007 Feb; 13(1):91-4. PubMed ID: 17250538
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reproducibility of the durometer and myoton devices for skin stiffness measurement in healthy subjects.
    Dellalana LE; Chen F; Vain A; Gandelman JS; Põldemaa M; Chen H; Tkaczyk ER
    Skin Res Technol; 2019 May; 25(3):289-293. PubMed ID: 30414198
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Quantification of cutaneous sclerosis with a skin elasticity meter in patients with generalized scleroderma.
    Enomoto DN; Mekkes JR; Bossuyt PM; Hoekzema R; Bos JD
    J Am Acad Dermatol; 1996 Sep; 35(3 Pt 1):381-7. PubMed ID: 8784273
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interrater reproducibility of the Myoton and durometer devices to quantify sclerotic chronic graft-versus-host disease.
    Ghosh S; Baker L; Chen F; Khera Z; Vain A; Zhang K; Hood A; Smith H; Chen H; Jagasia M; Tkaczyk E
    Arch Dermatol Res; 2023 Nov; 315(9):2545-2554. PubMed ID: 37227518
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Skin involvement in systemic sclerosis.
    Czirják L; Foeldvari I; Müller-Ladner U
    Rheumatology (Oxford); 2008 Oct; 47 Suppl 5():v44-5. PubMed ID: 18784142
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluating the cutaneous involvement in scleroderma: torsional stiffness revisited.
    Knight LR; Smeathers JE; Isdale AH; Helliwell PS
    Rheumatology (Oxford); 2001 Feb; 40(2):128-32. PubMed ID: 11257147
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Is it possible to reduce observer variability in skin score assessment of scleroderma? The ad hoc International Group on the Assessment of Disease Outcome in Scleroderma.
    Silman A; Harrison M; Brennan P
    J Rheumatol; 1995 Jul; 22(7):1277-80. PubMed ID: 7562758
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A novel approach to measuring skin elasticity in systemic sclerosis: results from a pilot study.
    Galarraga B; McSwiggan S; Caswell FR; Brodie RC; Sharma P; Abel EW; Newton DJ; Belch JJ
    Scand J Rheumatol; 2011 May; 40(3):211-6. PubMed ID: 21231806
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sodium nitroprusside iontophoresis on the finger pad does not consistently increase skin blood flow in healthy controls and patients with systemic sclerosis.
    Roustit M; Blaise S; Cracowski JL
    Microvasc Res; 2009 May; 77(3):260-4. PubMed ID: 19272396
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vivo study of skin mechanical properties in patients with systemic sclerosis.
    Dobrev HP
    J Am Acad Dermatol; 1999 Mar; 40(3):436-42. PubMed ID: 10071315
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.